A comparative study of three ternary complexes prepared in different mixing orders of siRNA/redox-responsive hyperbranched poly (amido amine)/hyaluronic acid

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 3837-3849

  Chen, Cheng Jun ^a   Zhao, Zhi Xia ^a   Wang, Jian Cheng ^a   Zhao, En Yu ^a   Gao, Ling Yan ^a   Zhou, Shu Feng ^b   Liu, Xiao Yan ^a   Lu, Wan Liang ^a   Zhang, Qiang ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Hyaluronic acid; Mixing order; Poly(amido amine)s; SiRNA delivery; SiRNA ternary complex; Small interfering RNA

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID; POLYAMIDOAMINE; SMALL INTERFERING RNA; VASCULOTROPIN;

ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL TRANSPORT; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG COATING; DRUG EFFICACY; DRUG STABILITY; FLUORESCENCE ANALYSIS; GENE DELIVERY SYSTEM; GENE SILENCING; HUMAN; HUMAN CELL; PARTICLE SIZE; PHOTOCHEMICAL QUENCHING; PROTEIN EXPRESSION; STATIC ELECTRICITY; STRUCTURE ANALYSIS; ZETA POTENTIAL;

ANALYSIS OF VARIANCE; CELL LINE, TUMOR; DRUG CARRIERS; DRUG STABILITY; FLUORESCEIN; GENE SILENCING; GENE TRANSFER TECHNIQUES; HUMANS; HYALURONIC ACID; OXIDATION-REDUCTION; POLYAMINES; RNA, SMALL INTERFERING; SPECTROMETRY, FLUORESCENCE; TECHNOLOGY, PHARMACEUTICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84870365509     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S32676     Document Type: Article

References (44)

1. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001;411(6836):494-498.
2. Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS, Khvorova A. Rational siRNA design for RNA interference. Nat Biotechnol. 2004;22(3):326-330.
3. Tebes SJ, Kruk PA. The genesis of RNA interference, its potential clinical applications, and implications in gynecologic cancer. Gynecol Oncol. 2005;99(3):736-741.
4. Whitehead KA, Langer R, Anderson DG. Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov. 2009;8(2): 129-138.
5. Kim DH, Rossi JJ. Strategies for silencing human disease using RNA interference. Nat Rev Genet. 2007;8(3):173-184.
6. Schiffelers RM, Ansari A, Xu J, etal. Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res. 2004;32(19):e149.
7. Cavazzana-Calvo M, Thrasher A, Mavilio F. The future of gene therapy. Nature. 2004;427(6977):779-781.
8. Boussif O, Lezoualc'h F, Zanta MA, etal. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A. 1995;92(16):7297-7301.
9. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, etal. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science. 2000;288(5466):669-672.
10. Juliano R, Bauman J, Kang H, Ming X. Biological barriers to therapy with antisense and siRNA oligonucleotides. Mol Pharm. 2009;6(3):686-695.
11. Pack DW, Hoffman AS, Pun S, Stayton PS. Design and development of polymers for gene delivery. Nat Rev Drug Discov. 2005;4(7): 581-593.
12. Jeong JH, Kim SW, Park TG. Molecular design of functional polymers for gene therapy. Prog Polym Sci. 2007;32(11):1239-1274.
13. Bauhuber S, Hozsa C, Breunig M, Göpferich A. Delivery of nucleic acids via disulfide-based carrier systems. Adv Mater. 2009;21(32-33): 3286-3306.
14. Meng F, Hennink WE, Zhong Z. Reduction-sensitive polymers and bioconjugates for biomedical applications. Biomaterials. 2009;30(12):2180-2198.
15. Jere D, Kim JE, Arote R, etal. Akt1silencing efficiencies in lung cancer cells by sh/si/ssiRNA transfection using a reductable polyspermine carrier. Biomaterials. 2009;30(8):1635-1647.
16. Piest M, Lin C, Mateos-Timoneda MA, etal. Novel poly(amido amine)s with bioreducible disulfide linkages in their diamino-units: structure effects and in vitro gene transfer properties. J Control Release. 2008;130(1):38-45.
17. Christensen LV, Chang CW, Kim WJ, etal. Reducible poly(amido ethylenimine)s designed for triggered intracellular gene delivery. Bioconjug Chem. 2006;17(5):1233-1240.
18. Breunig M, Hozsa C, Lungwitz U, etal. Mechanistic investigation of poly(ethylene imine)-based siRNA delivery: disulfide bonds boost intracellular release of the cargo. J Control Release. 2008;130(1):57-63.
19. Ou M, Xu R, Kim SH, Bull DA, Kim SW. A family of bioreducible poly(disulfide amine)s for gene delivery. Biomaterials. 2009;30(29):5804-5814.
20. Koo H, Jin GW, Kang H, etal. Biodegradable branched poly(ethylenimine sulfide) for gene delivery. Biomaterials. 2010;31(5): 988-997.
21. Lin C, Blaauboer CJ, Timoneda MM, etal. Bioreducible poly(amido amine)s with oligoamine side chains: synthesis, characterization, and structural effects on gene delivery. J Control Release. 2008;126(2): 166-174.
22. Son S, Singha K, Kim WJ. Bioreducible BPEI-SS-PEG-cNGR polymer as a tumor targeted nonviral gene carrier. Biomaterials. 2010;31(24): 6344-6354.
23. Wang R, Zhou L, Zhou Y, etal. Synthesis and gene delivery of poly(amido amine)s with different branched architecture. Biomacromolecules. 2010;11(2):489-495.
24. Kurosaki T, Kitahara T, Fumoto S, etal. Ternary complexes of pDNA, polyethylenimine, and gamma-polyglutamic acid for gene delivery systems. Biomaterials. 2009;30(14):2846-2853.
25. Duceppe N, Tabrizian M. Factors influencing the transfection efficiency of ultra low molecular weight chitosan/hyaluronic acid nanoparticles. Biomaterials. 2009;30(13):2625-2631.
26. Ito T, Yoshihara C, Hamada K, Koyama Y. DNA/polyethyleneimine/hyaluronic acid small complex particles and tumor suppression in mice. Biomaterials. 2010;31(10):2912-2918.
27. Xu P, Quick GK, Yeo Y. Gene delivery through the use of a hyaluronate-associated intracellularly degradable crosslinked polyethyleneimine. Biomaterials. 2009;30(29):5834-5843.
28. Oh EJ, Park K, Kim KS, etal. Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives. J Control Release. 2010;141(1):2-12.
29. Yao J, Fan Y, Du R, etal. Amphoteric hyaluronic acid derivative for targeting gene delivery. Biomaterials. 2010;31(35):9357-9365.
30. Götte M, Yip GW. Heparanase, hyaluronan, and CD44in cancers: a breast carcinoma perspective. Cancer Res. 2006;66(21):10233-10237.
31. Draffin JE, McFarlane S, Hill A, Johnston PG, Waugh DJ. CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells. Cancer Res. 2004;64(16):5702-5711.
32. Sheridan C, Kishimoto H, Fuchs RK, etal. CD44+/CD24-breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res. 2006;8(5):R59.
33. Eliaz RE, Szoka FC Jr. Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells. Cancer Res. 2001;61(6):2592-2601.
34. Ito T, Koyama Y, Otsuka M. Analysis of the surface structure of DNA/polycation/hyaluronic acid ternary complex by Raman microscopy. J Pharm Biomed Anal. 2010;51(1):268-272.
35. Ito T, Iida-Tanaka N, Niidome T, etal. Hyaluronic acid and its derivative as a multi-functional gene expression enhancer: protection from non-specific interactions, adhesion to targeted cells, and transcriptional activation. J Control Release. 2006;112(3):382-388.
36. Chen J, Wu C, Oupický D. Bioreducible hyperbranched poly(amido amine)s for gene delivery. Biomacromolecules. 2009;10(10):2921-2927.
37. Hong CY, You YZ, Wu DC, Liu Y, Pan CY. Thermal control over the topology of cleavable polymers: from linear to hyperbranched structures. J Am Chem Soc. 2007;129(17):5354-5355.
38. Vader P, van der Aa LJ, Engbersen JF, Storm G, Schiffelers RM. A method for quantifying cellular uptake of fluorescently labeled siRNA. J Control Release. 2010;148(1):106-109.
39. Takei Y, Kadomatsu K, Yuzawa Y, Matsuo S, Muramatsu T. A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics. Cancer Res. 2004;64(10):3365-3370.
40. Kim SH, Jeong JH, Kim TI, Kim SW, Bull DA. VEGF siRNA delivery system using arginine-grafted bioreducible poly(disulfide amine). Mol Pharm. 2009;6(3):718-726.
41. Lim EK, Kim HO, Jang E, etal. Hyaluronan-modified magnetic nanoclusters for detection of CD44-overexpressing breast cancer by MR imaging. Biomaterials. 2011;32(31):7941-7950.
42. Merkel OM, Beyerle A, Librizzi D, etal. Nonviral siRNA delivery to the lung: investigation of PEG-PEI polyplexes and their in vivo performance. Mol Pharm. 2009;6(4):1246-1260.
43. Schaffer DV, Fidelman NA, Dan N, Lauffenburger DA. Vector unpacking as a potential barrier for receptor-mediated polyplex gene delivery. Biotechnol Bioeng. 2000;67(5):598-606.
44. Hoon Jeong J, Christensen LV, Yockman JW, etal. Reducible poly(amido ethylenimine) directed to enhance RNA interference. Biomaterials. 2007;28(10):1912-1917.